Skip to main content

Table 3 Associations of Bisphenols with CVD subgroup risk

From: The bisphenol F and bisphenol S and cardiovascular disease: results from NHANES 2013–2016

variables Congestive heart failure (n = 35) Coronary heart disease (n = 53) Angina pectoris (n = 26) Heart attack (n = 59) Stroke (n = 48)
Bisphenol S
 T1 Reference Reference Reference Reference Reference
 T2 1.05 (0.32, 3.51) 1.09 (0.39, 3.05) 2.89 (0.86, 9.68) 0.54 (0.23, 1.30) 0.85 (0.22, 3.27)
 T3 0.87 (0.28, 2.69) 2.22 (1.04, 4.74) 3.15 (0.81, 12.19) 0.98 (0.47, 2.02) 2.64 (0.82, 8.52)
P for trend 0.794 0.036* 0.089 0.936 0.109
Bisphenol F
 T1 Reference Reference Reference Reference Reference
 T2 1.34 (0.46, 3.87) 2.55 (0.93, 6.99) 1.70 (0.58, 5.02) 3.07 (1.21, 7.78) 1.48 (0.42, 5.19)
 T3 1.08 (0.33, 3.59) 2.24 (0.58, 8.65) 3.98 (0.93, 17.12) 2.72 (0.72, 10.30) 0.96 (0.25, 3.73)
 P for trend 0.904 0.295 0.073 0.164 0.924
Bisphenol A
 T1 Reference Reference Reference Reference Reference
 T2 0.67 (0.23, 1.93) 0.84 (0.31, 2.34) 1.21 (0.35, 4.16) 0.39 (0.12, 1.28) 0.91 (0.36, 2.30)
 T3 0.58 (0.18, 1.89) 0.73 (0.17, 3.12) 0.84 (0.15, 4.67) 1.52 (0.46, 4.98) 0.57 (0.22, 1.46)
 P for trend 0.356 0.655 0.873 0.593 0.275
  1. Adjusted for sex, age, race, education level, PIR, physical activity, alcohol drinking status, smoking status, BMI, blood pressure, cancer, diabetes, LDL-C level, energy intake, and urine creatinine concentration; * p< 0.05; ** p< 0.01; *** p< 0.001. The bold values indicate statistically significant differences